Plasmodium falciparum purine nucleoside phosphorylase is critical for viability of malaria parasites

Dennis C. Madrid, Li Min Ting, Karena L. Waller, Vern L. Schramm, Kami Kim

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Human malaria infections resulting from Plasmodium falciparum have become increasingly difficult to treat due to the emergence of drug-resistant parasites. The P. falciparum purine salvage enzyme purine nucleoside phosphorylase (PfPNP) is a potential drug target. Previous studies, in which PfPNP was targeted by transition state analogue inhibitors, found that those inhibiting human PNP and PfPNPs killed P. falciparum in vitro. However, many drugs have off-target interactions, and genetic evidence is required to demonstrate single target action for this class of potential drugs. We used targeted gene disruption in P. falciparum strain 3D7 to ablate PNP expression, yielding transgenic 3D7 parasites (Δpfpnp). Lysates of the Δpfpnp parasites showed no PNP activity, but activity of another purine salvage enzyme, adenosine deaminase (PfADA), was normal. When compared with wild-type 3D7, the Δpfpnp parasites showed a greater requirement for exogenous purines and a severe growth defect at physiological concentrations of hypoxanthine. Drug assays using immucillins, specific transition state inhibitors of PNP, were performed on wild-type and Δpfpnp parasites. The Δpfpnp parasites were more sensitive to PNP inhibitors that bound hPNP tighter and less sensitive to MT-ImmH, an inhibitor with 100-fold preference for PfPNP over hPNP. The results demonstrate the importance of purine salvage in P. falciparum and validate PfPNP as the target of immucillins.

Original languageEnglish (US)
Pages (from-to)35899-35907
Number of pages9
JournalJournal of Biological Chemistry
Volume283
Issue number51
DOIs
StatePublished - Dec 19 2008

Fingerprint

Purine-Nucleoside Phosphorylase
Salvaging
Plasmodium falciparum
Malaria
Parasites
Enzymes
Pharmaceutical Preparations
Purines
Hypoxanthine
Adenosine Deaminase
purine
Assays
Genes
Action Potentials
Defects

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Plasmodium falciparum purine nucleoside phosphorylase is critical for viability of malaria parasites. / Madrid, Dennis C.; Ting, Li Min; Waller, Karena L.; Schramm, Vern L.; Kim, Kami.

In: Journal of Biological Chemistry, Vol. 283, No. 51, 19.12.2008, p. 35899-35907.

Research output: Contribution to journalArticle

Madrid, Dennis C. ; Ting, Li Min ; Waller, Karena L. ; Schramm, Vern L. ; Kim, Kami. / Plasmodium falciparum purine nucleoside phosphorylase is critical for viability of malaria parasites. In: Journal of Biological Chemistry. 2008 ; Vol. 283, No. 51. pp. 35899-35907.
@article{b99910464f7e4b6f9cd761664090397f,
title = "Plasmodium falciparum purine nucleoside phosphorylase is critical for viability of malaria parasites",
abstract = "Human malaria infections resulting from Plasmodium falciparum have become increasingly difficult to treat due to the emergence of drug-resistant parasites. The P. falciparum purine salvage enzyme purine nucleoside phosphorylase (PfPNP) is a potential drug target. Previous studies, in which PfPNP was targeted by transition state analogue inhibitors, found that those inhibiting human PNP and PfPNPs killed P. falciparum in vitro. However, many drugs have off-target interactions, and genetic evidence is required to demonstrate single target action for this class of potential drugs. We used targeted gene disruption in P. falciparum strain 3D7 to ablate PNP expression, yielding transgenic 3D7 parasites (Δpfpnp). Lysates of the Δpfpnp parasites showed no PNP activity, but activity of another purine salvage enzyme, adenosine deaminase (PfADA), was normal. When compared with wild-type 3D7, the Δpfpnp parasites showed a greater requirement for exogenous purines and a severe growth defect at physiological concentrations of hypoxanthine. Drug assays using immucillins, specific transition state inhibitors of PNP, were performed on wild-type and Δpfpnp parasites. The Δpfpnp parasites were more sensitive to PNP inhibitors that bound hPNP tighter and less sensitive to MT-ImmH, an inhibitor with 100-fold preference for PfPNP over hPNP. The results demonstrate the importance of purine salvage in P. falciparum and validate PfPNP as the target of immucillins.",
author = "Madrid, {Dennis C.} and Ting, {Li Min} and Waller, {Karena L.} and Schramm, {Vern L.} and Kami Kim",
year = "2008",
month = "12",
day = "19",
doi = "10.1074/jbc.M807218200",
language = "English (US)",
volume = "283",
pages = "35899--35907",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "51",

}

TY - JOUR

T1 - Plasmodium falciparum purine nucleoside phosphorylase is critical for viability of malaria parasites

AU - Madrid, Dennis C.

AU - Ting, Li Min

AU - Waller, Karena L.

AU - Schramm, Vern L.

AU - Kim, Kami

PY - 2008/12/19

Y1 - 2008/12/19

N2 - Human malaria infections resulting from Plasmodium falciparum have become increasingly difficult to treat due to the emergence of drug-resistant parasites. The P. falciparum purine salvage enzyme purine nucleoside phosphorylase (PfPNP) is a potential drug target. Previous studies, in which PfPNP was targeted by transition state analogue inhibitors, found that those inhibiting human PNP and PfPNPs killed P. falciparum in vitro. However, many drugs have off-target interactions, and genetic evidence is required to demonstrate single target action for this class of potential drugs. We used targeted gene disruption in P. falciparum strain 3D7 to ablate PNP expression, yielding transgenic 3D7 parasites (Δpfpnp). Lysates of the Δpfpnp parasites showed no PNP activity, but activity of another purine salvage enzyme, adenosine deaminase (PfADA), was normal. When compared with wild-type 3D7, the Δpfpnp parasites showed a greater requirement for exogenous purines and a severe growth defect at physiological concentrations of hypoxanthine. Drug assays using immucillins, specific transition state inhibitors of PNP, were performed on wild-type and Δpfpnp parasites. The Δpfpnp parasites were more sensitive to PNP inhibitors that bound hPNP tighter and less sensitive to MT-ImmH, an inhibitor with 100-fold preference for PfPNP over hPNP. The results demonstrate the importance of purine salvage in P. falciparum and validate PfPNP as the target of immucillins.

AB - Human malaria infections resulting from Plasmodium falciparum have become increasingly difficult to treat due to the emergence of drug-resistant parasites. The P. falciparum purine salvage enzyme purine nucleoside phosphorylase (PfPNP) is a potential drug target. Previous studies, in which PfPNP was targeted by transition state analogue inhibitors, found that those inhibiting human PNP and PfPNPs killed P. falciparum in vitro. However, many drugs have off-target interactions, and genetic evidence is required to demonstrate single target action for this class of potential drugs. We used targeted gene disruption in P. falciparum strain 3D7 to ablate PNP expression, yielding transgenic 3D7 parasites (Δpfpnp). Lysates of the Δpfpnp parasites showed no PNP activity, but activity of another purine salvage enzyme, adenosine deaminase (PfADA), was normal. When compared with wild-type 3D7, the Δpfpnp parasites showed a greater requirement for exogenous purines and a severe growth defect at physiological concentrations of hypoxanthine. Drug assays using immucillins, specific transition state inhibitors of PNP, were performed on wild-type and Δpfpnp parasites. The Δpfpnp parasites were more sensitive to PNP inhibitors that bound hPNP tighter and less sensitive to MT-ImmH, an inhibitor with 100-fold preference for PfPNP over hPNP. The results demonstrate the importance of purine salvage in P. falciparum and validate PfPNP as the target of immucillins.

UR - http://www.scopus.com/inward/record.url?scp=58149093352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149093352&partnerID=8YFLogxK

U2 - 10.1074/jbc.M807218200

DO - 10.1074/jbc.M807218200

M3 - Article

C2 - 18957439

AN - SCOPUS:58149093352

VL - 283

SP - 35899

EP - 35907

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 51

ER -